Reuters first to report SoftBank leads latest Alto Pharmacy funding round | Reuters News Agency

Reuters first to report SoftBank leads latest Alto Pharmacy funding round

Reuters was first to report that SoftBank’s Vision Fund 2 was leading a $250 million investment in Silicon Valley-based startup Alto Pharmacy. SoftBank’s Vision Fund II contributed a majority of the funding round. At one point, the fund considered investing as much as $300 million but eventually decided to limit its exposure. Other existing investors in Alto, including Greenoaks Capital and Jackson Square Ventures, also participated in the Series D round.

Article Tags
Type: Reuters Best
Sectors: Equities
Regions: Asia
Win Types: Exclusivity
Story Types: Exclusive / Scoop
5e3c7c2d-b9c0-431f-9eef-23a5ac130004
Sign up for email updates
Subscribe
Sign up for email updates